XK and influenza: Inhibition of influenza virus NA activity is the mechanism‐of‐action of the US Food and Drug Administration currently approved anti‐influenza antivirals, Tamiflu (oseltamivir phosphate), Relenza (zanamivir) and Rapivab (peramivir) [217, 218, 219].